The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Paraneoplastic anti– N ‐methyl‐ D ‐aspartate receptor encephalitis associated with ovarian teratoma
Open accessAbstract
OBJECTIVE: To report the autoantigens of a new category of treatment-responsive paraneoplastic encephalitis. METHODS: Analysis of clinical features, neuropathological findings, tumors, and serum/cerebrospinal fluid antibodies using rat tissue, neuronal cultures, and HEK293 cells expressing subunits of the N-methyl-D-aspartate receptor (NMDAR). RESULTS: Twelve women (14-44 years) developed prominent psychiatric symptoms, amnesia, seizures, frequent dyskinesias, autonomic dysfunction, and decreased level of consciousness often requiring ventilatory support. All had serum/cerebrospinal fluid antibodies that predominantly immunolabeled the neuropil of hippocampus/forebrain, in particular the cell surface of hippocampal neurons, and reacted with NR2B (and to a lesser extent NR2A) subunits of the NMDAR. NR2B binds glutamate and forms heteromers (NR1/NR2B or NR1/NR2A/NR2B) that are preferentially expressed in the adult hippocampus/forebrain. Expression of functional heteromers (not single subunits) was required for antibody binding. Eleven patients had teratoma of the ovary (six mature) and one a mature teratoma in the mediastinum; five of five tumors examined contained nervous tissue that strongly expressed NR2 subunits and reacted with patients' antibodies. Tumor resection and immunotherapy resulted in improvement or full recovery of eight of nine patients (paralleled by decreased antibody titers); two of three patients without tumor resection died of neurological deterioration. Autopsies showed extensive microgliosis, rare T-cell infiltrates, and neuronal degeneration predominantly involving, but not restricted to, the hippocampus. INTERPRETATION: Antibodies to NR2B- and NR2A-containing heteromers of the NMDAR associate with a severe but treatment-responsive encephalitis. Our findings provide a diagnostic test and suggest a model of autoimmune NMDAR-related encephalitis with broad implications for other immune-mediated disorders of memory, behavior, and cognition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Preliminary studies suggested the target epitopes were located in extracellular regions of NR1–NR2B NMDA receptors.5”
From Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies (2008) · cites this paper as [5]
In the citing paper
“We recently identified a disorder, designated anti-NMDA-receptor encephalitis, that associates with antibodies against NR1–NR2 heteromers and results in a characteristic neuropsychiatric syndrome.5”
From Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies (2008) · cites this paper as [5]
In the citing paper
“The first patients identified were young women with ovarian teratoma who presented with psychosis or memory problems, rapidly progressing to multiple neurological deficits requiring prolonged intensive care support.”
From Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies (2008) · cites this paper as [5]
In the citing paper
“Serum and CSF were tested for antibodies against the NMDA receptor,5 and considered positive if three immunohistochemical criteria were fulfilled (figure 1).”
From Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies (2008) · cites this paper as [5]
In the citing paper
“Despite the severity of the disorder, patients often recovered after tumour removal and immunotherapy, suggesting an immune-mediated pathogenesis.”
From Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies (2008) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Monyer, H., Burnashev, N., Laurie, D. J., Sakmann, B., & Seeburg, P. H. (1994) · Neuron · doi:10.1016/0896-6273(94)90210-0 · Cited by 3,535
Gultekin, S. H. (2000) · Brain · doi:10.1093/brain/123.7.1481 · Cited by 1,110
Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients
Graus, F. (2001) · Brain · doi:10.1093/brain/124.6.1138 · Cited by 891
DeGiorgio, L. A., Konstantinov, K. N., Lee, S. C., Hardin, J., Volpe, B. T., & Diamond, B. (2001) · Nature Medicine · doi:10.1038/nm1101-1189 · Cited by 798
Clinical analysis of anti-Ma2-associated encephalitis
Dalmau, J. O. (2004) · Brain · doi:10.1093/brain/awh203 · Cited by 776
Antigen unmasking on formalin‐fixed, paraffin‐embedded tissue sections
Cattoretti, G., Pileri, S. A., Parravicini, C., Becker, M. H. G., Poggi, S., Bifulco, C. B., Key, G., D'Amato, L., Sabattini, E., Feudale, E. A. A., et al. (1993) · The Journal of Pathology · doi:10.1002/path.1711710205 · Cited by 721
Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma
Vitaliani, R., Mason, W. P., Ances, B. M., Zwerdling, T., Jiang, Z., & Dalmau, J. O. (2005) · Annals of Neurology · doi:10.1002/ana.20614 · Cited by 604
Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates
Ances, B. M., Vitaliani, R., Taylor, R. A., Liebeskind, D. S., Voloschin, A. D., Houghton, D. J., Galetta, S. L., Dichter, M. A., Alavi, A. A., Rosenfeld, M. R., et al. (2005) · Brain · doi:10.1093/brain/awh526 · Cited by 486
Laube, B., Hirai, H., Sturgess, M., Betz, H., & Kuhse, J. (1997) · Neuron · doi:10.1016/s0896-6273(00)81249-0 · Cited by 476
Wenzel, A., Fritschy, J., Möhler, H., & Benke, D. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68020469.x · Cited by 442
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 1,000
Ovarian teratoma-associated anti-NMDAR encephalitis: a systematic review of reported cases
Acién, P., Acién, M., Ruiz-Maciá, E., & Martín-Estefanía, C. (2014) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-014-0157-x · Cited by 98
Testicular teratoma and anti-N-methyl-D-aspartate receptor-associated encephalitis
Eker, A., Saka, E., Dalmau, J. O., Kurne, A., Bilen, C. Y., Özen, H., Ertoy, D., Oğuz, K. K., & Elibol, B. (2008) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.147611 · Cited by 96
Iizuka, T., Kaneko, J., Tominaga, N., Someko, H., Nakamura, M., Ishima, D., Kitamura, E., Masuda, R., Oguni, E., Yanagisawa, T., et al. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.0232 · Cited by 97
Risk factors for mortality in patients with anti-NMDA receptor encephalitis
Chi, X., Wang, W., Huang, C., Wu, M., Zhang, L., Li, J., & Zhou, D. (2016) · Acta Neurologica Scandinavica · doi:10.1111/ane.12723 · Cited by 96
Pan, H., Oliveira, B., Saher, G., Dere, E., Tapken, D., Mitjans, M., Seidel, J., Wesolowski, J., Wakhloo, D., Klein-Schmidt, C., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-017-0011-3 · Cited by 98
Is it time for immunopsychiatry in psychotic disorders?
Leboyer, M., Oliveira, J., Tamouza, R., & Groc, L. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4266-1 · Cited by 98
The 2010 Revised Classification of Seizures and Epilepsy
Berg, A. T., & Millichap, J. G. (2013) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000431377.44312.9e · Cited by 95
Anti-NMDA Receptor Encephalitis: Clinical Features and Basic Mechanisms
Lynch, D. R., Rattelle, A., Dong, Y., Roslin, K., Gleichman, A. J., & Panzer, J. A. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.08.005 · Cited by 95
Anti-NMDA Receptor Autoimmune Encephalitis: Diagnosis and Management Strategies
Nguyen, L., & Wang, C. (2023) · International Journal of General Medicine · doi:10.2147/ijgm.s397429 · Cited by 95
Anti-NMDA-Receptor Encephalitis: Case Report and Literature Review of an Under-Recognized Condition
Day, G. S., High, S., Cot, B., & Tang‐Wai, D. F. (2011) · Journal of General Internal Medicine · doi:10.1007/s11606-011-1641-9 · Cited by 93
Maneta, E., & García, G. (2013) · Psychosomatics · doi:10.1016/j.psym.2013.06.002 · Cited by 92
VZV brainstem encephalitis triggers NMDA receptor immunoreaction
Schäbitz, W., Rogalewski, A., Hagemeister, C., & Bien, C. G. (2014) · Neurology · doi:10.1212/wnl.0000000000001072 · Cited by 92
Long-term Functional Outcomes and Relapse of Anti-NMDA Receptor Encephalitis
Gong, X., Chen, C., Liu, X., Lin, J., Li, A., Guo, K., Zhou, D., & Hong, Z. (2021) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000958 · Cited by 91
Seronegative autoimmune diseases: A challenging diagnosis
Lenti, M. V., Rossi, C. M., Melazzini, F., Gastaldi, M., Bugatti, S., Rotondi, M., Bianchi, P. I., Gentile, A., Chiovato, L., Montecucco, C., et al. (2022) · Autoimmunity Reviews · doi:10.1016/j.autrev.2022.103143 · Cited by 99
Paraneoplastic neurological syndromes: diagnosis and treatment
Graus, F., & Dalmau, J. O. (2008) · Current Opinion in Internal Medicine · doi:10.1097/wco.0b013e3282f189dc · Cited by 92
Germ Cell Tumors of the Ovary: An Update
Nogales, F. F., Dulcey, I., & Preda, O. (2014) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2012-0547-ra · Cited by 92
Crisp, S. J., Kullmann, D. M., & Vincent, A. C. (2016) · Nature reviews. Neuroscience · doi:10.1038/nrn.2015.27 · Cited by 92
Jarius, S., & Wildemann, B. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0357-x · Cited by 91
NMDA Receptor Internalization by Autoantibodies: A Reversible Mechanism Underlying Psychosis?
Masdeu, J. C., Dalmau, J. O., & Berman, K. F. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.02.006 · Cited by 92
Neuro-Ophthalmologic Manifestations of Paraneoplastic Syndromes
Ko, M. W., Dalmau, J. O., & Galetta, S. L. (2008) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0b013e3181677fcc · Cited by 91
Wegner, F., Wilke, F., Raab, P., Tayeb, S. B., Boeck, A.-L., Haense, C., Trebst, C., Voß, E. V., Schrader, C., Logemann, F., et al. (2014) · BMC Neurology · doi:10.1186/1471-2377-14-136 · Cited by 91
Diagnosis and Treatment of Chorea Syndromes
Hermann, A., & Walker, R. H. (2015) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0514-0 · Cited by 90
The recognition and treatment of autoimmune epilepsy in children
Suleiman, J., & Dale, R. C. (2014) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.12647 · Cited by 89
Liu, C., Zhu, J., Zheng, X., Ma, C., & Wang, X. (2017) · Mediators of Inflammation · doi:10.1155/2017/6361479 · Cited by 89
New‐onset refractory status epilepticus and febrile infection‐related epilepsy syndrome
Specchio, N., & Pietrafusa, N. (2020) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.14553 · Cited by 89
Autoimmune Disorders of the Nervous System: Pathophysiology, Clinical Features, and Therapy
Bhagavati, S. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.664664 · Cited by 89
Antibody-Mediated Autoimmune Encephalopathies and Immunotherapies
Gastaldi, M., Thouin, A., & Vincent, A. C. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0410-6 · Cited by 88
Plasma exchange in pediatric anti-NMDAR encephalitis: A systematic review
Suppiej, A., Nosadini, M., Zuliani, L., Pelizza, M. F., Toldo, I., Bertossi, C., Tison, T., Zoccarato, M., Marson, P., Giometto, B., et al. (2016) · Brain and Development · doi:10.1016/j.braindev.2016.01.009 · Cited by 88
Davies, G. R., Irani, S. R., Coltart, C. E. M., Ingle, G. T., Amin, Y., Taylor, C., Radcliffe, J. J., Hirsch, N. P., Howard, R., Vincent, A. C., et al. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181cb0968 · Cited by 86
Anti-N-methyl-D-aspartate-receptor encephalitis: diagnosis, optimal management, and challenges
Mann, A. P., Lukas, R. V., & Grebenciucova, E. (2014) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s61967 · Cited by 87
Paraneoplastic Neurological Syndromes
Toothaker, T. B., & Rubin, M. (2009) · The Neurologist · doi:10.1097/nrl.0b013e3181870aa2 · Cited by 86
Stein, H., Barbosa, J., Rosa-Justícia, M., Prades, L., Morató, A., Galan-Gadea, A., Ariño, H., Martínez‐Hernández, E., Castro‐Fornieles, J., Dalmau, J. O., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18033-3 · Cited by 80
Innate and adaptive immunity in human epilepsies
Bauer, J., Becker, A. J., Elyaman, W., Peltola, J., Rüegg, S. J., Titulaer, M. J., Varley, J. A., & Beghi, E. (2017) · Epilepsia · doi:10.1111/epi.13784 · Cited by 86
Vincent, A. C., & Bien, C. G. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70225-4 · Cited by 85
Updates in the Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes
Grativvol, R. S., Cavalcante, W. C. P., Castro, L. H. M., Nitríni, R., & Simabukuro, M. M. (2018) · Current Oncology Reports · doi:10.1007/s11912-018-0721-y · Cited by 84
Leypoldt, F., Wandinger, K.-P., Bien, C. G., & Dalmau, J. O. (2012) · European Neurological Review · doi:10.17925/enr.2013.08.01.31 · Cited by 86
Wesselingh, R., Butzkueven, H., Buzzard, K., Tarlinton, D., O'Brien, T. J., & Monif, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02066 · Cited by 83
HLA class II alleleDRB1*16:02is associated with anti-NMDAR encephalitis
Shu, Y., Qiu, W., Zheng, J., Sun, X., Yin, J., Yang, X., Yue, X., Chen, C., Deng, Z., Li, S., et al. (2019) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-319714 · Cited by 83
Ovarian Teratoma Associated With Anti-N-Methyl D-Aspartate Receptor Encephalitis
Dabner, M., McCluggage, W. G., Bundell, C., Carr, A. S., Leung, Y. C., Sharma, R. N., & Stewart, C. J. R. (2012) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e31824a1de2 · Cited by 84
Claustrum damage and refractory status epilepticus following febrile illness
Meletti, S., Slonková, J., Marečková, I., Monti, G., Specchio, N., Hon, P., Giovannini, G., Marcián, V., Chiari, A., Krůpa, P., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001996 · Cited by 83
Neural antigen‐specific autoimmune disorders
Iorio, R., & Lennon, V. A. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01144.x · Cited by 82
Inflammation, ictogenesis, and epileptogenesis: An exploration through human disease
Tan, T., Perucca, P., O'Brien, T. J., Kwan, P., & Monif, M. (2020) · Epilepsia · doi:10.1111/epi.16788 · Cited by 82
Antibody-Mediated Autoimmune Encephalitis in Childhood
Brenton, J. N., & Goodkin, H. P. (2016) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2016.04.004 · Cited by 82
Newman, M., Blum, S., Wong, R. C. W., Scott, J. G., Prain, K. M., Wilson, R. J., & Gillis, D. (2016) · Internal Medicine Journal · doi:10.1111/imj.12974 · Cited by 81
Bortezomib Treatment for Patients With Anti-N-Methyl- d -Aspartate Receptor Encephalitis
Behrendt, V., Krogias, C., Reinacher‐Schick, A., Gold, R., & Kleiter, I. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.2588 · Cited by 81
Pediatric autoimmune encephalitis
Barbagallo, M., Vitaliti, G., Pavone, P., Romano, C., Lubrano, R., & Falsaperla, R. (2017) · Journal of Pediatric Neurosciences · doi:10.4103/jpn.jpn_185_16 · Cited by 81
Antibodies to the N-Methyl-D-Aspartate Receptor and Other Synaptic Proteins in Psychosis
Deakin, J., Lennox, B., & Zandi, M. S. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.07.018 · Cited by 81
Zhang, Y., Liu, G., Jiang, M., Li, L. P., & Su, Y. (2017) · Clinical Neurophysiology · doi:10.1016/j.clinph.2017.04.015 · Cited by 80
Catatonia in patients with anti‐NMDA receptor encephalitis
Espínola-Nadurille, M., Flores-Rivera, J. D. J., Rivas‐Alonso, V., Vargas‐Cañas, S., Fricchione, G. L., Bayliss, L., Martínez-Juárez, I. E., Hernández‐Vanegas, L. E., Martinez‐Hernandez, R., Bautista‐Gomez, P., et al. (2019) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12867 · Cited by 80
The autoantibody-mediated encephalitides: from clinical observations to molecular pathogenesis
Ramanathan, S., Al‐Diwani, A., Waters, P. J., & Irani, S. R. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09590-9 · Cited by 80
Structural mechanisms of GABAA receptor autoimmune encephalitis
Noviello, C., Kreye, J., Teng, J., Prüß, H., & Hibbs, R. E. (2022) · Cell · doi:10.1016/j.cell.2022.06.025 · Cited by 79
Mimics of Autoimmune Encephalitis
van Steenhoven, R. W., de Vries, J. M., Bruijstens, A. L., Paunovic, M., Nagtzaam, M. M. P., Franken, S. C., Bastiaansen, A. E. M., de Bruijn, M. A. A. M., van Sonderen, A., Schreurs, M. W. J., et al. (2023) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200148 · Cited by 81
Blood–Brain Barrier Disruption in Neuroimmunological Disease
Shimizu, F., & Nakamori, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910625 · Cited by 88
Qin, K., Wu, W., Huang, Y., Xu, D., Zhang, L., Zheng, B., Jiang, M., Kou, C., Gao, J., Li, W., et al. (2017) · BMC Neurology · doi:10.1186/s12883-016-0787-9 · Cited by 78
Frequencies of neuronal autoantibodies in healthy controls
Lang, K., & Prüß, H. (2017) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000386 · Cited by 78
Zuliani, L., Nosadini, M., Gastaldi, M., Spatola, M., Iorio, R., Zoccarato, M., Mariotto, S., Gaspari, P. D., Perini, F., Ferrari, S., et al. (2019) · Neurological Sciences · doi:10.1007/s10072-019-03930-3 · Cited by 79
Kirkpatrick, M. P., Clarke, C. D., Sonmezturk, H. H., & Abou-Khalil, B. W. (2010) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2010.11.020 · Cited by 77
Understanding and managing acute encephalitis
Kumar, R. K. (2020) · F1000Research · doi:10.12688/f1000research.20634.1 · Cited by 78
Infectious and Autoimmune Causes of Encephalitis in Children
Erickson, T. A., Muscal, E., Muñoz, F. M., Lotze, T. E., Hasbun, R., Brown, E. L., & Murray, K. O. (2020) · PEDIATRICS · doi:10.1542/peds.2019-2543 · Cited by 77
Luca, N. J. C., Daengsuwan, T., Dalmau, J. O., Jones, K., deVeber, G., Kobayashi, J. S., Laxer, R. M., & Benseler, S. M. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30437 · Cited by 78
Autoimmune and inflammatory mechanisms of CNS damage
Kapadia, M., & Šakić, B. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.008 · Cited by 75
Neuropathological Variability within a Spectrum of NMDAR ‐Encephalitis
Zrzavy, T., Endmayr, V., Bauer, J., Macher, S., Mossaheb, N., Schwaiger, C., Ricken, G., Winklehner, M., Glatter, S., Breu, M., et al. (2021) · Annals of Neurology · doi:10.1002/ana.26223 · Cited by 77
Clinical Characteristics of Anti-GABA-B Receptor Encephalitis
Zhu, F., Shan, W., Lv, R., Li, Z., & Wang, Q. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00403 · Cited by 75
Autoimmune Encephalitis: Current Knowledge on Subtypes, Disease Mechanisms and Treatment
Nissen, M. S., Ryding, M., Meyer, M., & Blaabjerg, M. (2020) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527319666200708133103 · Cited by 76
Antigenic and mechanistic characterization of anti‐ AMPA receptor encephalitis
Gleichman, A. J., Panzer, J. A., Baumann, B. H., Dalmau, J. O., & Lynch, D. R. (2014) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.43 · Cited by 76
Hodgkin's Lymphoma: A Review of Neurologic Complications
Grimm, S. A., & Chamberlain, M. C. (2010) · Advances in Hematology · doi:10.1155/2011/624578 · Cited by 75
Sarkis, R. A., Coffey, M. J., Cooper, J. J., Hassan, I., & Lennox, B. (2018) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.18010005 · Cited by 75
Anti–NMDA Receptor Encephalitis
Jones, K., Benseler, S. M., & Moharir, M. D. (2013) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2012.12.009 · Cited by 75
Hansen, H.-C., Klingbeil, C., Dalmau, J. O., Li, W., Weißbrich, B., & Wandinger, K. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.585 · Cited by 74
Anti–NMDA-Receptor Encephalitis and Other Synaptic Autoimmune Disorders
Rosenfeld, M. R., & Dalmau, J. O. (2011) · Current Treatment Options in Neurology · doi:10.1007/s11940-011-0116-y · Cited by 75
Takahashi, Y., Mine, J., Kubota, Y., Yamazaki, E., & Fujiwara, T. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2008.01977.x · Cited by 67
Anti-NMDAR autoimmune encephalitis
Miya, K., Takahashi, Y., & Mori, H. (2013) · Brain and Development · doi:10.1016/j.braindev.2013.10.005 · Cited by 73
Successful treatment of anti-N-methyl-D-aspartate receptor encephalitis presenting with catatonia
Schimmel, M., Bien, C. G., Vincent, A. C., Schenk, W., & Penzien, J. M. (2009) · Archives of Disease in Childhood · doi:10.1136/adc.2008.149021 · Cited by 73
Recognizing Autoimmune-Mediated Encephalitis in the Differential Diagnosis of Limbic Disorders
da Rocha, A. J., Nunes, R. H., Maia, A. C. M., & do Amaral, L. L. F. (2015) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4408 · Cited by 73
Britton, J. W. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63432-0.00013-x · Cited by 72
Expanding Spectrum of Encephalitis With NMDA Receptor Antibodies in Young Children
Lebas, A., Husson, B., Didelot, A., Honnorat, J., & Tardieu, M. (2009) · Journal of Child Neurology · doi:10.1177/0883073809343319 · Cited by 70
Pollak, T. A., Beck, K., Irani, S. R., Howes, O. D., David, A. S., & McGuire, P. K. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4156-y · Cited by 72
Obi-Nagata, K., Temma, Y., & Hayashi‐Takagi, A. (2019) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.95.014 · Cited by 72
Epidemiology of Antibody-Positive Autoimmune Encephalitis in Southwest China: A Multicenter Study
Gu, Y., Zhong, M., He, L., Li, W., Huang, Y., Liu, J., Chen, Y., & Xiao, Z. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02611 · Cited by 71
Wu, C., Wu, J., & Chen, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222010911 · Cited by 74
The diagnosis and treatment of limbic encephalitis
Asztély, F., & Kumlien, E. (2012) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2012.01691.x · Cited by 71
Epidemiology of viral encephalitis in 2011
Stahl, J. ‐., Mailles, A., Dacheux, L., & Morand, P. (2011) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2011.05.015 · Cited by 71
Autoimmune encephalitis in psychiatric institutions: current perspectives
Bost, C., Pascual, O., & Honnorat, J. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s82380 · Cited by 73
Autoimmune Basal Ganglia Disorders
Dale, R. C., & Brilot, F. (2012) · Journal of Child Neurology · doi:10.1177/0883073812451327 · Cited by 71
Meletti, S., Giovannini, G., d’Orsi, G., Toran, L., Monti, G., Guha, R., Kiryttopoulos, A., Pascarella, M. G., Martino, T., Alexopoulos, H., et al. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00111 · Cited by 70
A mouse model of seizures in anti– N ‐methyl‐ d ‐aspartate receptor encephalitis
Taraschenko, O. D., Fox, H. S., Pittock, S. J., Ζεκερίδου, Α., Gafurova, M., Eldridge, E., Liu, J., Dravid, S. M., & Dingledine, R. J. (2019) · Epilepsia · doi:10.1111/epi.14662 · Cited by 68
Trends in Psychiatry and Psychotherapy
(2020) · Trends in Psychiatry and Psychotherapy · doi:10.47626/2237-6089 · Cited by 70
Autoantibody-mediated diseases of the CNS: Structure, dysfunction and therapy
Varley, J. A., Taylor, J., & Irani, S. R. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.04.046 · Cited by 70
Allosteric signaling and dynamics of the clamshell-like NMDA receptor GluN1 N-terminal domain
Zhu, S., Stroebel, D., Yao, C. A., Taly, A., & Paoletti, P. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2522 · Cited by 69
van Coevorden‐Hameete, M. H., de Graaff, E., Titulaer, M. J., Hoogenraad, C. C., & Smitt, P. A. E. S. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.10.016 · Cited by 71
Mann, A. P., Machado, N. M., Liu, N., Mazin, A.-H., Silver, K. M., & Afzal, K. I. (2012) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.11070151 · Cited by 69
Dai, Y., Zhang, J., Ren, H., Zhou, X., Chen, J., Cui, L., Lang, J., Guan, H., & Sun, D. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.05.026 · Cited by 68
Therapeutic plasma exchange for the treatment of anti‐NMDA receptor encephalitis
Pham, H. P., Daniel‐Johnson, J. A., Stotler, B. A., Stephens, H. L., & Schwartz, J. E. (2011) · Journal of Clinical Apheresis · doi:10.1002/jca.20311 · Cited by 68
Tay, S. H., Fairhurst, A., & Mak, A. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.12.002 · Cited by 66
“Autoimmune Epilepsy”: Encephalitis with Autoantibodies for Epileptologists
Bien, C. G., & Holtkamp, M. (2017) · Epiliepsy currents/Epilepsy currents · doi:10.5698/1535-7511.17.3.134 · Cited by 68
Short- and Long-Lived Autoantibody-Secreting Cells in Autoimmune Neurological Disorders
Zografou, C., Vakrakou, A. G., & Stathopoulos, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.686466 · Cited by 67
Complex partial status epilepticus revealing anti‐NMDA receptor encephalitis
Bayreuther, C., Bourg, V., Dellamonica, J., Borg, M., Bernardin, G., & Thomas, P. (2009) · Epileptic Disorders · doi:10.1684/epd.2009.0266 · Cited by 66
Neuronal Surface Antibody-Mediated Autoimmune Encephalitis
Linnoila, J., Rosenfeld, M. R., & Dalmau, J. O. (2014) · Seminars in Neurology · doi:10.1055/s-0034-1390394 · Cited by 67
McKeon, G. L., Scott, J. G., Spooner, D., Ryan, A. E., Blum, S., Gillis, D., Langguth, D., & Robinson, G. A. (2016) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617716000679 · Cited by 69
The Neuroimmunology of Schizophrenia
Annya, M., Smyth, Stephen, M., & Lawrie, S. M. (2013) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2013.11.3.107 · Cited by 68
Metadata
- Authors
- Dalmau, J., Tüzün, E., Wu, H., Masjuan, J., Rossi, J. E., Voloschin, A., Baehring, J. M., Shimazaki, H., Koide, R., King, D., Mason, W., Sansing, L. H., Dichter, M. A., Rosenfeld, M. R., & Lynch, D. R.
- Affiliations
- University of Pennsylvania (US)
- Augusta University (US)
- Yale University (US)
- Jichi Medical University (JP)
- Tokyo Metropolitan Neurological Hospital (JP)
- Children's Hospital of Pittsburgh (US)
- Princess Margaret Cancer Centre (CA)
- Corresponding author
- Dalmau, Josep
- ORCID
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2007-01
- Volume
- 61
- Issue
- 1
- Pages
- 25-36
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- PMC
- PMC2430743
- OpenAlex
- W2114398221
- Cited by
- 2,492
- References
- 37
- Citations by year
- 2026: 105 · 2025: 122 · 2024: 142 · 2023: 135 · 2022: 168 · 2021: 190 · 2020: 158 · 2019: 179 · 2018: 128 · 2017: 152 · 2016: 158 · 2015: 145 · 2014: 129 · 2013: 143 · 2012: 113
- FWCI
- 47.94
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA089054, R01CA107192)
- National Institute of Neurological Disorders and Stroke (R01NS045986)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Autoimmune Neurological Disorders and Treatments
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Clinical Neurology › Myasthenia Gravis and Thymoma
- Keywords
- paraneoplastic encephalitis, anti-NMDA receptor encephalitis, ovarian teratoma, NMDA receptor subunits, NR2B, NR2A, autoantibodies, hippocampal neurons, autoimmune encephalitis, tumor resection, immunotherapy, microglial activation, neurodegeneration, psychiatric symptoms, amnesia, seizures
- MeSH terms
- Adolescent, Adult, Animals, Antibodies, Dissection, Encephalitis, Female, Humans, Immunohistochemistry, Immunosuppressive Agents, Magnetic Resonance Imaging, Male, Neurons, Ovarian Neoplasms, Teratoma, Transfection, Gene Expression Regulation, Neoplastic, Receptors, N-Methyl-D-Aspartate, Treatment Outcome, Rats, Wistar, Protein Subunits, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
